181 🩺 Amniotic Fluid Embolism Part 1 | Guidelines & Cohort Studies — Dx. and Mgmt. | Anes & OB/GYN

🚨 Sudden cardiorespiratory collapse during labor — amniotic fluid embolism (AFE) is rare, unpredictable, and one of the leading causes of maternal mortality worldwide. Most clinicians will encounter this catastrophic emergency only once or twice in a career, making evidence-based preparation essential. 📖 This lecture (Part 1) reviews AFE from a clinical guidelines perspective, using four SMFM guideline documents as the primary evidence base, supplemented by five major cohort studies and reviews covering epidemiology, risk factors, and outcomes. 🔍 Topics Covered AFE pathophysiology — anaphylactoid syndrome of pregnancy, maternal-fetal interface disruption, proinflammatory cascade activation Biphasic hemodynamic response — acute right ventricular failure transitioning to left ventricular failure 20-year US epidemiological trends — stable incidence (4.9/100,000 deliveries), declining case fatality rate (mean 17.7%) Clinical diagnosis — exclusion diagnosis principle (SMFM 2016, GRADE 1C), no confirmatory laboratory test Clark et al. 2016 proposed research case definition — four required criteria and their clinical implications US International AFE Registry analysis — 46% typical AFE, 21% misclassified as AFE (actually PPH-related hypovolemic shock) Risk factors across cohort studies — placental accreta spectrum (PAS) as the strongest risk factor (aOR 10.01) Cardiac arrest management — high-quality CPR, lateral uterine displacement, perimortem cesarean delivery at 4 minutes Hemodynamic support — echocardiography-guided management, inotropes (dobutamine, milrinone), pulmonary vasodilators (inhaled NO, prostacyclin, sildenafil), vasopressors over fluid resuscitation Coagulopathy management — 1:1:1 hemostatic resuscitation, cryoprecipitate, tranexamic acid, thromboelastography, rFVIIa as last resort, ECMO consideration SMFM Checklist 2021 — complete structure, 3 clinical domains, implementation strategy Multicountry outcomes (Fitzpatrick 2019) — 30–41% fatality or permanent neurological injury; obstetrician/anaesthetist presence improves outcomes (aOR 0.38 for poor outcome) Failure-to-rescue rates — 17% overall; exceeds 45% in AFE with cardiac arrest and coagulopathy Future directions — A-OK regimen, validated biomarkers, standardized multidisciplinary response protocols 🎯 From medical students to experienced subspecialists, this review builds the knowledge framework needed to recognize and manage AFE rapidly and effectively when it counts most. #AmnioticFluidEmbolism #AFE #MaternalEmergency #Anesthesia #ObstetricsGynecology #SMFMGuidelines #CPRinPregnancy #DIC #Coagulopathy #PlacentalAccretaSpectrum #PerinatalEmergency #MaternalMortality #ECMO #TranexamicAcid #ObstetricEmergency #AnesthesiaReview #MaternalCriticalCare #ClinicalGuidelines #EvidenceBasedMedicine